News

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...
The U.S. Food and Drug Administration has approved three vaccines for RSV — GSK's Arexvy, Moderna's mRESVIA and Pfizer's ...
The ACG has published new health maintenance recommendations for patients with IBD, which include appropriate vaccinations, ...